Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin

American Journal Geriatric Pharmacotherapy

Volumn 9, Issue 6, 2011, Pages 471-482

  Swindle, Jason P ^a   Potash, Jesse ^a   Kulakodlu, Mahesh ^a   Kuznik, Andreas ^b   Buikema, Ami ^a  

^a OPTUM   (United States)

^b PFIZER INC   (United States)

Author keywords

adherence; atorvastatin; cardiovascular events; elderly; retrospective; simvastatin

Indexed keywords

ATORVASTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

AGED; AORTA ANEURYSM; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COMORBIDITY; DRUG UTILIZATION; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVASCULARIZATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; COHORT STUDIES; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICATION ADHERENCE; MULTIVARIATE ANALYSIS; PYRROLES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SIMVASTATIN; TREATMENT OUTCOME; UNITED STATES;

EID: 83555166277     PISSN: 15435946     EISSN: 18767761     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2011.09.004     Document Type: Article

References (42)

1. National Heart, Lung, and Blood Institute Morbidity and mortality: 2009 chart book on cardiovascular, lung, and blood diseases http://www.nhlbi.nih.gov/ resources/docs/cht-book.htm Accessed March 7, 2010
2. American Heart Association 2010 Statistical Fact Sheet http://www.americanheart.org Accessed February 20, 2010
3. American Heart Association Risk Factors http://www.americanheart.org Accessed February 20, 2010
4. P.W. Wilson, W.B. Kannel Obesity, diabetes, and risk of cardiovascular disease in the elderly Am J Geriatr Cardiol 11 2002 119 123 125
5. A.W. Weverling-Rijnsburger, G.J. Blauw, A.M. Lagaay Total cholesterol and risk of mortality in the oldest old Lancet 350 1997 1119 1123 (Pubitemid 27454002)
6. W.B. Kannel Epidemiology of cardiovascular disease in the elderly: an assessment of risk factors Cardiovasc Clin 22 1992 9 22
7. I.J. Schatz, K. Masaki, K. Yano Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study Lancet 358 2001 351 355 (Pubitemid 32739094)
8. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
9. S.D. Candrilli, A. Kuznik, P.M. Mendys, D.J. Wilson The prevalence and coexistence of cardiovascular comorbidities among the US dyslipidemic aged <65 years, by lipid lowering medication use status Postgrad Med 122 2010 142 149
10. A.P. Lea, D. McTavish Atorvastatin A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias Drugs 53 1997 828 847 (Pubitemid 27195013)
11. G.D. Kolovou, A. Katerina, V. Ioannis, D.V. Cokkinos Simvastatin: two decades in a circle Cardiovasc Ther 26 2008 166 178 (Pubitemid 351945130)
12. P. Jones, S. Kafonek, I. Laurora, D. Hunninghake Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) Am J Cardiol 81 1998 582 587 (Pubitemid 28182422)
13. S.L. Rogers, D.J. Magliano, D.B. Levison A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin Clin Ther 29 2007 242 252 (Pubitemid 46654221)
14. T.R. Pedersen, O. Faergeman, J.J. Kastelein High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial JAMA 294 2005 2437 2445 (Pubitemid 41627921)
15. P. Deedwania, P.H. Stone, C.N. Bairey Merz Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE) Circulation 115 2007 700 707 (Pubitemid 46294760)
16. N.K. Wenger, S.J. Lewis, D.M. Herrington Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease Ann Intern Med 147 2007 1 9 (Pubitemid 351664628)
17. T.A. Miettinen, K. Pyörl, A.G. Olsson Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S) Circulation 96 1997 4211 4218 (Pubitemid 28007446)
18. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
19. P.S. Sever, B. Dahlöf, N.R. Poulter Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes TrialLipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial Drugs 64 Suppl 2 2004 43 60 (Pubitemid 39657106)
20. J.G. Robinson Lipid-lowering therapy for the primary prevention of cardiovascular disease in the elderly: opportunities and challenges Drugs Aging 26 2009 917 931
21. H.A. Neil, D.A. DeMicco, D. Luo Analysis of efficacy and safety in patients aged 6575 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS) Diabetes Care 29 2006 2378 2384 (Pubitemid 44912239)
22. S. Ghosh, V. Ziesmer, W.S. Aronow Underutilization of aspirin, beta blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs and overutilization of calcium channel blockers in older persons with coronary artery disease in an academic nursing home J Gerontol A Biol Sci Med Sci 57 2002 M398 M400
23. C.A. Allen Maycock, J.B. Muhlestein, B.D. Horne Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients J Am Coll Cardiol 40 2002 1777 1785 (Pubitemid 35341956)
24. S. DeWilde, I.M. Carey, S.A. Bremner Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? Heart 89 2003 417 421 (Pubitemid 36379415)
25. M. Cournot, J.P. Cambou, S. Quentzel, N. Danchin Key factors associated with the under-prescription of statins in elderly coronary heart disease patients: results from the ELIAGE and ELICOEUR surveys Int J Cardiol 111 2006 12 18 (Pubitemid 44107532)
26. M. Law, A.R. Rudnicka Statin safety: a systematic review Am J Cardiol 97 Suppl 8A 2006 52C 60C
27. M.H. Davidson Treatment of the elderly with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors: focus on drug interactions J Cardiovasc Pharmacol Ther 6 2001 219 229 (Pubitemid 34296584)
28. B.P. Maroo, C.J. Lavie, R.V. Milani Secondary prevention of coronary heart disease in elderly patients following myocardial infarction: are all HMG-CoA reductase inhibitors alike? Drugs Aging 25 2008 649 664
29. M.H. Davidson, J.G. Robinson Safety of aggressive lipid management J Am Coll Cardiol 49 2007 1753 1762 (Pubitemid 46617861)
30. J.A. de Lemos, M.A. Blazing, S.D. Wiviott Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA 292 2004 1307 1316 (Pubitemid 39223221)
31. N.K. Choudhry, R. Levin, W.C. Winkelmayer Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice Heart 93 2007 945 951 (Pubitemid 47122045)
32. M.E. Charlson, P. Pompei, K.L. Ales, C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chron Dis 40 1987 373 383 (Pubitemid 17055592)
33. H. Quan, V. Sundararajan, P. Halfon Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Med Care 43 2005 1130 1339
34. C.A. Jackevicius, M. Mamdani, J.V. Tu Adherence with statin therapy in elderly patients with and without acute coronary syndromes JAMA 288 2002 462 467 (Pubitemid 34787477)
35. J.S. Benner, R.J. Glynn, H. Mogun Long-term persistence in use of statin therapy in elderly patients JAMA 288 2002 455 461 (Pubitemid 34787476)
36. K.K. Ray, R.G. Bach, C.P. Cannon Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS Eur Heart J 27 2006 2310 2316 (Pubitemid 44453574)
37. T.A. Jacobson, D.A. Wertz, T. Hoy Comparison of cardiovascular event rates in patients without cardiovascular disease in whom atorvastatin or simvastatin was newly initiated Mayo Clin Proc 83 2008 1316 1325
38. J.M. Foody, A.T. Joyce, A.E. Rudolph Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States Clin Ther 30 2008 195 205 (Pubitemid 351834719)
39. R.J. Willke, S. Zhou, R.A. Vogel Differences in cardiovascular event rates between atorvastatin and simvastatin among new users: managed-care experience Curr Med Res Opin 24 2008 2873 2882
40. Z. Zhou, E. Rahme, M. Abrahamowicz Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect CMAJ 172 2005 1187 1194 (Pubitemid 40592675)
41. C.R. Harley, S. Gandhi, J. Blasetto Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice Am J Geriatr Pharmacother 5 2007 185 194 (Pubitemid 350054285)
42. J.M. Foody, A.T. Joyce, A.E. Rudolph Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study Curr Med Res Opin 24 2008 1987 2000